95 related articles for article (PubMed ID: 9813656)
1. Humoral and cellular immune responses of dogs immunized with a nucleic acid vaccine encoding human carcinoembryonic antigen.
Smith BF; Baker HJ; Curiel DT; Jiang W; Conry RM
Gene Ther; 1998 Jul; 5(7):865-8. PubMed ID: 9813656
[TBL] [Abstract][Full Text] [Related]
2. Induction of anti-tumor immunity by intrasplenic administration of a carcinoembryonic antigen DNA vaccine.
White SA; LoBuglio AF; Arani RB; Pike MJ; Moore SE; Barlow DL; Conry RM
J Gene Med; 2000; 2(2):135-40. PubMed ID: 10809147
[TBL] [Abstract][Full Text] [Related]
3. Late administration of plasmid DNA by intradermal electroporation efficiently boosts DNA-primed T and B cell responses to carcinoembryonic antigen.
Bråve A; Hallengärd D; Gudmundsdotter L; Stout R; Walters R; Wahren B; Hallermalm K
Vaccine; 2009 Jun; 27(28):3692-6. PubMed ID: 19428161
[TBL] [Abstract][Full Text] [Related]
4. Polynucleotide immunization of nonhuman primates against carcinoembryonic antigen.
Conry RM; White SA; Fultz PN; Khazaeli MB; Strong TV; Allen KO; Barlow DL; Moore SE; Coan PN; Davis I; Curiel DT; LoBuglio AF
Clin Cancer Res; 1998 Nov; 4(11):2903-12. PubMed ID: 9829759
[TBL] [Abstract][Full Text] [Related]
5. Immune response to a carcinoembryonic antigen polynucleotide vaccine.
Conry RM; LoBuglio AF; Kantor J; Schlom J; Loechel F; Moore SE; Sumerel LA; Barlow DL; Abrams S; Curiel DT
Cancer Res; 1994 Mar; 54(5):1164-8. PubMed ID: 8118800
[TBL] [Abstract][Full Text] [Related]
6. A carcinoembryonic antigen polynucleotide vaccine for human clinical use.
Conry RM; LoBuglio AF; Loechel F; Moore SE; Sumerel LA; Barlow DL; Pike J; Curiel DT
Cancer Gene Ther; 1995 Mar; 2(1):33-8. PubMed ID: 7621253
[TBL] [Abstract][Full Text] [Related]
7. IL-12 plasmid-enhanced DNA vaccination against carcinoembryonic antigen (CEA) studied in immune-gene knockout mice.
Song K; Chang Y; Prud'homme GJ
Gene Ther; 2000 Sep; 7(18):1527-35. PubMed ID: 11021590
[TBL] [Abstract][Full Text] [Related]
8. Comparative evaluation of three different intramuscular delivery methods for DNA immunization in a nonhuman primate animal model.
Rao SS; Gomez P; Mascola JR; Dang V; Krivulka GR; Yu F; Lord CI; Shen L; Bailer R; Nabel GJ; Letvin NL
Vaccine; 2006 Jan; 24(3):367-73. PubMed ID: 16194587
[TBL] [Abstract][Full Text] [Related]
9. Safety and immunogenicity of a DNA vaccine encoding carcinoembryonic antigen and hepatitis B surface antigen in colorectal carcinoma patients.
Conry RM; Curiel DT; Strong TV; Moore SE; Allen KO; Barlow DL; Shaw DR; LoBuglio AF
Clin Cancer Res; 2002 Sep; 8(9):2782-7. PubMed ID: 12231517
[TBL] [Abstract][Full Text] [Related]
10. Phase I trial of a recombinant vaccinia virus encoding carcinoembryonic antigen in metastatic adenocarcinoma: comparison of intradermal versus subcutaneous administration.
Conry RM; Khazaeli MB; Saleh MN; Allen KO; Barlow DL; Moore SE; Craig D; Arani RB; Schlom J; LoBuglio AF
Clin Cancer Res; 1999 Sep; 5(9):2330-7. PubMed ID: 10499601
[TBL] [Abstract][Full Text] [Related]
11. Intranasal immunization with liposome-encapsulated plasmid DNA encoding influenza virus hemagglutinin elicits mucosal, cellular and humoral immune responses.
Wang D; Christopher ME; Nagata LP; Zabielski MA; Li H; Wong JP; Samuel J
J Clin Virol; 2004 Dec; 31 Suppl 1():S99-106. PubMed ID: 15567101
[TBL] [Abstract][Full Text] [Related]
12. [Immunization with targeted fusion anticaries DNA vaccine via intramuscular route:experiment with murine].
Yu F; Fan MW; Xu QA; Jia R; Guo JH; Bian Z; Chen Z; Peng B; Fan B
Zhonghua Yi Xue Za Zhi; 2004 May; 84(9):754-9. PubMed ID: 15200917
[TBL] [Abstract][Full Text] [Related]
13. Safety and immunological efficacy of a prostate cancer plasmid DNA vaccine encoding prostatic acid phosphatase (PAP).
Johnson LE; Frye TP; Arnot AR; Marquette C; Couture LA; Gendron-Fitzpatrick A; McNeel DG
Vaccine; 2006 Jan; 24(3):293-303. PubMed ID: 16115700
[TBL] [Abstract][Full Text] [Related]
14. Multigene/multisubtype HIV-1 vaccine induces potent cellular and humoral immune responses by needle-free intradermal delivery.
Bråve A; Ljungberg K; Boberg A; Rollman E; Isaguliants M; Lundgren B; Blomberg P; Hinkula J; Wahren B
Mol Ther; 2005 Dec; 12(6):1197-205. PubMed ID: 16112909
[TBL] [Abstract][Full Text] [Related]
15. Signal sequence deletion and fusion to tetanus toxoid epitope augment antitumor immune responses to a human carcinoembryonic antigen (CEA) plasmid DNA vaccine in a murine test system.
Lund LH; Andersson K; Zuber B; Karlsson A; Engström G; Hinkula J; Wahren B; Winberg G
Cancer Gene Ther; 2003 May; 10(5):365-76. PubMed ID: 12719706
[TBL] [Abstract][Full Text] [Related]
16. Regulation of T-helper-1 versus T-helper-2 activity and enhancement of tumor immunity by combined DNA-based vaccination and nonviral cytokine gene transfer.
Song K; Chang Y; Prud'homme GJ
Gene Ther; 2000 Mar; 7(6):481-92. PubMed ID: 10757021
[TBL] [Abstract][Full Text] [Related]
17. A carcinoembryonic antigen polynucleotide vaccine has in vivo antitumor activity.
Conry RM; LoBuglio AF; Loechel F; Moore SE; Sumerel LA; Barlow DL; Curiel DT
Gene Ther; 1995 Jan; 2(1):59-65. PubMed ID: 7712333
[TBL] [Abstract][Full Text] [Related]
18. Vaccination with plasmid DNA encoding KMPII, TRYP, LACK and GP63 does not protect dogs against Leishmania infantum experimental challenge.
Rodríguez-Cortés A; Ojeda A; López-Fuertes L; Timón M; Altet L; Solano-Gallego L; Sánchez-Robert E; Francino O; Alberola J
Vaccine; 2007 Nov; 25(46):7962-71. PubMed ID: 17942199
[TBL] [Abstract][Full Text] [Related]
19. Responses of mice immunized with a DNA vaccine encoding carcinoembryonic antigen (CEA).
Johansson S; Engström G; Winberg G; Hinkula J; Wahren B
Vaccine; 2006 May; 24(21):4572-5. PubMed ID: 16159686
[TBL] [Abstract][Full Text] [Related]
20. A DNA vaccine encoding genetic fusions of carcinoembryonic antigen (CEA) and granulocyte/macrophage colony-stimulating factor (GM-CSF).
Lima J; Jenkins C; Guerrero A; Triozzi PL; Shaw DR; Strong TV
Vaccine; 2005 Jan; 23(10):1273-83. PubMed ID: 15652670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
